Cargando…
A Rare Cause of Uveitis: Vemurafenib
A 25-year-old female presented with a decrease of vision and redness in both eyes. She had a history of nodular melanoma in her right shoulder, which was excised surgically and she was under oral vemurafenib treatment. She was diagnosed with moderately severe bilateral panuveitis and hospitalized fo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330668/ https://www.ncbi.nlm.nih.gov/pubmed/30605942 http://dx.doi.org/10.4274/tjo.95914 |
_version_ | 1783387009331494912 |
---|---|
author | Sızmaz, Selçuk Görkemli, Nuhkan Esen, Ebru Demircan, Nihal |
author_facet | Sızmaz, Selçuk Görkemli, Nuhkan Esen, Ebru Demircan, Nihal |
author_sort | Sızmaz, Selçuk |
collection | PubMed |
description | A 25-year-old female presented with a decrease of vision and redness in both eyes. She had a history of nodular melanoma in her right shoulder, which was excised surgically and she was under oral vemurafenib treatment. She was diagnosed with moderately severe bilateral panuveitis and hospitalized for systemic investigation and workup. The laboratory test results were unremarkable and systemic workup failed to reveal an etiology. The condition was considered vemurafenib-induced uveitis, as the drug is known to be associated with uveitis. After reevaluation with the oncology department, vemurafenib was stopped and topical and systemic corticosteroid therapy was started. The uveitis resolved and her vision returned to normal. No sign of recurrence was detected at 8-month follow-up. |
format | Online Article Text |
id | pubmed-6330668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-63306682019-01-23 A Rare Cause of Uveitis: Vemurafenib Sızmaz, Selçuk Görkemli, Nuhkan Esen, Ebru Demircan, Nihal Turk J Ophthalmol Case Report A 25-year-old female presented with a decrease of vision and redness in both eyes. She had a history of nodular melanoma in her right shoulder, which was excised surgically and she was under oral vemurafenib treatment. She was diagnosed with moderately severe bilateral panuveitis and hospitalized for systemic investigation and workup. The laboratory test results were unremarkable and systemic workup failed to reveal an etiology. The condition was considered vemurafenib-induced uveitis, as the drug is known to be associated with uveitis. After reevaluation with the oncology department, vemurafenib was stopped and topical and systemic corticosteroid therapy was started. The uveitis resolved and her vision returned to normal. No sign of recurrence was detected at 8-month follow-up. Galenos Publishing 2018-12 2018-12-27 /pmc/articles/PMC6330668/ /pubmed/30605942 http://dx.doi.org/10.4274/tjo.95914 Text en © 2018 by Turkish Ophthalmological Association Turkish Journal of Ophthalmology, published by Galenos Publishing House. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Sızmaz, Selçuk Görkemli, Nuhkan Esen, Ebru Demircan, Nihal A Rare Cause of Uveitis: Vemurafenib |
title | A Rare Cause of Uveitis: Vemurafenib |
title_full | A Rare Cause of Uveitis: Vemurafenib |
title_fullStr | A Rare Cause of Uveitis: Vemurafenib |
title_full_unstemmed | A Rare Cause of Uveitis: Vemurafenib |
title_short | A Rare Cause of Uveitis: Vemurafenib |
title_sort | rare cause of uveitis: vemurafenib |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330668/ https://www.ncbi.nlm.nih.gov/pubmed/30605942 http://dx.doi.org/10.4274/tjo.95914 |
work_keys_str_mv | AT sızmazselcuk ararecauseofuveitisvemurafenib AT gorkemlinuhkan ararecauseofuveitisvemurafenib AT esenebru ararecauseofuveitisvemurafenib AT demircannihal ararecauseofuveitisvemurafenib AT sızmazselcuk rarecauseofuveitisvemurafenib AT gorkemlinuhkan rarecauseofuveitisvemurafenib AT esenebru rarecauseofuveitisvemurafenib AT demircannihal rarecauseofuveitisvemurafenib |